Baxion
Screening
Tags
Alerts
Theme
MBX Biosciences, Inc.
MBX
·
NASDAQ
·
$31.75
Share Price as of 11/2
·
$1B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/12/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
10/22/26
8-K
Current report
08/27/26
8-K
Current report
08/06/26
8-K
Current report
07/13/26
8-K
Current report
06/12/26
Prospectuses and Registrations
Filter
S-3ASR
Automatic shelf registration
03/12/26
S-8
Registration of securities for employees
03/12/26
S-3
Shelf registration
11/06/25
424B4
Prospectus
09/25/25
S-1MEF
Prospectus / registration
09/24/25
Proxies
Filter
DEFA14A
Additional proxy materials
05/08/26
DEF 14A
Definitive proxy
04/22/26
DEFA14A
Additional proxy materials
04/22/26
DEF 14A
Definitive proxy
04/23/25
DEFA14A
Additional proxy materials
04/23/25
Ownership
Filter
Form 3
Initial insider ownership
10/22/26
Form 4
Insider transaction
10/22/26
144
Proposed sale of securities
08/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13D/A
Beneficial ownership (amended)
08/10/26
Other
Filter
ARS
Annual report to shareholders
04/22/26
EFFECT
Request for effectiveness
12/08/25
CORRESP
Correspondence with the SEC
12/04/25
EFFECT
Request for effectiveness
09/24/25
CORRESP
Correspondence with the SEC
09/22/25
Latest Filings
Filter
8-K
Current report
10/22/26
8-K
Current report
08/27/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
8-K
Current report
07/13/26
Ownership
Filter
Form 3
Initial insider ownership
10/22/26
Form 4
Insider transaction
10/22/26
144
Proposed sale of securities
08/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13D/A
Beneficial ownership (amended)
08/10/26